Steven Peskin, MD, MBA, FACP: [What is the economic value of patient assistance programs?] [When] patient assistance programs are for individuals where there is economic hardship, and a biopharmaceutical company deems that it is appropriate, compassionate, and ethical to provide some assistance to select patients, then I think [they are] a very worthy thing.
There are other types of patient support programs. When most people mention patient assistance, they’re thinking of some economic or financial assistance. Sometimes, there might even be free medication given to certain people who can’t afford those medicines in the diabetes space or other areas. Again, those things are laudable, and worthy, and compassionate.
With adherence, endurance, persistency, or side effect management, sure, those things, we recognize, are ongoing. For some of those efforts, we will work and join with certain companies. In particular areas, we worked with one company around educating some of our folks that work in care coordination on end-of-life issues and palliative care. That’s been an area where we’ve worked through educational opportunities with biopharmaceutical companies. Those kinds of things, where the patient journey can be supported, or assisted, as it relates to a particular cancer episode, are appropriate, and we’ll certainly welcome that help from life sciences companies.
[When it comes to] educating our members, again, we have programs where we will occasionally work together. We’ve done this in diabetes. I don’t know that we’ve done this in cancer, specifically, but those are potentially available opportunities.
Again, we’ve worked with certain biopharmaceutical companies to educate some of our care coordinators or care managers as it relates to particular emerging science in a particular cancer type or, again, as I mentioned earlier, palliative care and advanced illness.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Health Equity and Access Weekly Roundup: April 27, 2024
April 27th 2024Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen